In PIK3CA‐mutant samples, concurrent PTEN loss was found in 82.4% (ASCC), 80% (VSCC), 66.3% (CSCC), and 56.5% (OSCC) of cases. This evidence concerns the gene PTEN and skin squamous cell carcinoma.